Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
  1. 4 Insider Changes in Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Executive or director change · Regulation FD disclosure
  4. 8-K Event Other events
  5. 4 Insider Changes in Ownership
  6. 8-K Event Results of operations
  7. 10-Q Report Quarterly Report
  8. SC 13G Stake Amended Statement of Ownership
  9. 4 Insider Changes in Ownership
  10. 8-K Event Other events
  11. 8-K Event Results of operations
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations · Regulation FD disclosure
  14. 10-Q Report Quarterly Report
  15. SC 13G Stake Amended Statement of Ownership
  16. 8-K Event Agreement ended · Results of operations · Regulation FD disclosure
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 5 of 8 · 156 filings